BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Gulik TM, Kloek JJ, Ruys AT, Busch OR, van Tienhoven GJ, Lameris JS, Rauws EA, Gouma DJ. Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival. Eur J Surg Oncol. 2011;37:65-71. [PMID: 21115233 DOI: 10.1016/j.ejso.2010.11.008] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Kitano Y, Yamashita Y, Nakagawa S, Okabe H, Imai K, Chikamoto A, Baba H. Effectiveness of surgery for recurrent cholangiocarcinoma: A single center experience and brief literature review. The American Journal of Surgery 2020;219:175-80. [DOI: 10.1016/j.amjsurg.2019.02.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Xiang S, Lau WY, Chen XP. Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis. 2015;30:159-171. [PMID: 25376337 DOI: 10.1007/s00384-014-2063-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
3 Engelbrecht MR, Katz SS, van Gulik TM, Laméris JS, van Delden OM. Imaging of Perihilar Cholangiocarcinoma. American Journal of Roentgenology 2015;204:782-91. [DOI: 10.2214/ajr.14.12830] [Cited by in Crossref: 36] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
4 Coelen RJS, de Keijzer MJ, Weijer R, Loukachov VV, Wiggers JK, Mul FPJ, van Wijk ACWA, Fong Y, Heger M, van Gulik TM. In vitro detection of cholangiocarcinoma cells using a fluorescent protein-expressing oncolytic herpes virus. Cancer Gene Ther 2017;24:227-32. [PMID: 28409558 DOI: 10.1038/cgt.2017.11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Ramos E. Principles of surgical resection in hilar cholangiocarcinoma. World J Gastrointest Oncol 2013; 5(7): 139-146 [PMID: 23919108 DOI: 10.4251/wjgo.v5.i7.139] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
6 Roos E, Strijker M, Franken LC, Busch OR, van Hooft JE, Klümpen HJ, van Laarhoven HW, Wilmink JW, Verheij J, van Gulik TM, Besselink MG. Comparison of short- and long-term outcomes between anatomical subtypes of resected biliary tract cancer in a Western high-volume center. HPB (Oxford) 2020;22:405-14. [PMID: 31494056 DOI: 10.1016/j.hpb.2019.07.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
7 Zaydfudim VM, Clark CJ, Kendrick ML, Que FG, Reid-Lombardo KM, Donohue JH, Farnell MB, Nagorney DM. Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma. Am J Surg 2013;206:159-65. [PMID: 23746658 DOI: 10.1016/j.amjsurg.2012.11.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
8 Ruys AT, Heuts SG, Rauws EA, Busch OR, Gouma DJ, van Gulik TM. Delay in surgical treatment of patients with hilar cholangiocarcinoma: does time impact outcomes? HPB (Oxford) 2014;16:469-74. [PMID: 24033549 DOI: 10.1111/hpb.12156] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
9 Pinotti E, Sandini M, Famularo S, Tamini N, Romano F, Gianotti L. Resection of the caudate lobe for the treatment of hilar cholangiocarcinoma. Minerva Chir 2019;74:348-58. [PMID: 29658674 DOI: 10.23736/S0026-4733.18.07498-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Ruys AT, van Haelst S, Busch OR, Rauws EA, Gouma DJ, van Gulik TM. Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients. World J Surg. 2012;36:2179-2186. [PMID: 22569746 DOI: 10.1007/s00268-012-1638-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
11 Sugawara G, Yokoyama Y, Ebata T, Mizuno T, Yagi T, Ando M, Nagino M. Duration of Antimicrobial Prophylaxis in Patients Undergoing Major Hepatectomy With Extrahepatic Bile Duct Resection: A Randomized Controlled Trial. Ann Surg 2018;267:142-8. [PMID: 27759623 DOI: 10.1097/SLA.0000000000002049] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 4.8] [Reference Citation Analysis]
12 Ratti F, Cipriani F, Fiorentini G, Hidalgo Salinas C, Catena M, Paganelli M, Aldrighetti L. Management of hilum infiltrating tumors of the liver: The impact of experience and standardization on outcome. Dig Liver Dis. 2019;51:135-141. [PMID: 30115572 DOI: 10.1016/j.dld.2018.07.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
13 van der Gaag NA, Kloek JJ, de Bakker JK, Musters B, Geskus RB, Busch OR, Bosma A, Gouma DJ, van Gulik TM. Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma. Ann Oncol. 2012;23:2642-2649. [PMID: 22532585 DOI: 10.1093/annonc/mds077] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
14 van Gulik TM, Ruys AT, Busch OR, Rauws EA, Gouma DJ. Extent of Liver Resection for Hilar Cholangiocarcinoma (Klatskin Tumor): How Much Is Enough? Dig Surg 2011;28:141-7. [DOI: 10.1159/000323825] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
15 Gringeri E, Gambato M, Sapisochin G, Ivanics T, Lynch EN, Mescoli C, Burra P, Cillo U, Russo FP. Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology. J Clin Med 2020;9:E1353. [PMID: 32380750 DOI: 10.3390/jcm9051353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Groot Koerkamp B, Wiggers JK, Allen PJ, Besselink MG, Blumgart LH, Busch OR, Coelen RJ, D'Angelica MI, DeMatteo RP, Gouma DJ, Kingham TP, Jarnagin WR, van Gulik TM. Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. J Am Coll Surg. 2015;221:1041-1049. [PMID: 26454735 DOI: 10.1016/j.jamcollsurg.2015.09.005] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 12.0] [Reference Citation Analysis]
17 Stremitzer S, Stift J, Laengle J, Schwarz C, Kaczirek K, Jones RP, Quinn LM, Fenwick SW, Diaz-Nieto R, Poston GJ, Malik HZ. Prognosis and Circumferential Margin in Patients with Resected Hilar Cholangiocarcinoma. Ann Surg Oncol 2021;28:1493-8. [PMID: 32914390 DOI: 10.1245/s10434-020-09105-1] [Reference Citation Analysis]
18 Sugawara G, Yokoyama Y, Ebata T, Igami T, Yamaguchi J, Mizuno T, Yagi T, Nagino M. Preoperative biliary colonization/infection caused by multidrug-resistant (MDR) pathogens in patients undergoing major hepatectomy with extrahepatic bile duct resection. Surgery 2018;163:1106-13. [PMID: 29398033 DOI: 10.1016/j.surg.2017.12.031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
19 Hong SB, Lee NK, Kim S, Son IW, Seo HI, Kim DU, Han SY, Kim TU. Structured reporting of CT or MRI for perihilar cholangiocarcinoma: usefulness for clinical planning and interdisciplinary communication. Jpn J Radiol 2021;39:349-56. [PMID: 33175312 DOI: 10.1007/s11604-020-01068-3] [Reference Citation Analysis]
20 Chen GF, Yu WD, Wang JR, Qi FZ, Qiu YD. The methods of preoperative biliary drainage for resectable hilar cholangiocarcinoma patients: A protocol for systematic review and meta analysis. Medicine (Baltimore) 2020;99:e20237. [PMID: 32481299 DOI: 10.1097/MD.0000000000020237] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Geers J, Jaekers J, Topal H, Aerts R, Vandoren C, Vanden Boer G, Topal B. Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma. World J Surg Oncol 2020;18:286. [PMID: 33143698 DOI: 10.1186/s12957-020-02060-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Neuhaus P, Thelen A, Jonas S, Puhl G, Denecke T, Veltzke-Schlieker W, Seehofer D. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol. 2012;19:1602-1608. [PMID: 21964888 DOI: 10.1245/s10434-011-2077-5] [Cited by in Crossref: 159] [Cited by in F6Publishing: 138] [Article Influence: 15.9] [Reference Citation Analysis]
23 Leng KM, Liu YP, Wang ZD, Zhong XY, Liao GQ, Kang PC, Cui YF, Jiang XM. Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection. Onco Targets Ther 2017;10:2257-66. [PMID: 28461760 DOI: 10.2147/OTT.S131873] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 Wiggers JK, Groot Koerkamp B, Coelen RJ, Rauws EA, Schattner MA, Nio CY, Brown KT, Gonen M, van Dieren S, van Lienden KP, Allen PJ, Besselink MG, Busch OR, D'Angelica MI, DeMatteo RP, Gouma DJ, Kingham TP, Jarnagin WR, van Gulik TM. Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainage. Endoscopy 2015;47:1124-31. [PMID: 26382308 DOI: 10.1055/s-0034-1392559] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
25 Ruys AT, Kate FJ, Busch OR, Engelbrecht MR, Gouma DJ, van Gulik TM. Metastatic lymph nodes in hilar cholangiocarcinoma: does size matter? HPB (Oxford). 2011;13:881-886. [PMID: 22081924 DOI: 10.1111/j.1477-2574.2011.00389.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
26 Wiggers JK, Te Riele WW, van Dongen TH, Verheij J, Busch OR, van Gulik TM. Combined liver and extrahepatic bile duct resection for biliary invasion of colorectal metastasis: a case-cohort analysis and systematic review. Hepatobiliary Surg Nutr 2016;5:350-7. [PMID: 27500147 DOI: 10.21037/hbsn.2016.05.01] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
27 Farges O, Regimbeau JM, Fuks D, Le Treut YP, Cherqui D, Bachellier P, Mabrut JY, Adham M, Pruvot FR, Gigot JF. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg. 2013;100:274-283. [PMID: 23124720 DOI: 10.1002/bjs.8950] [Cited by in Crossref: 125] [Cited by in F6Publishing: 106] [Article Influence: 13.9] [Reference Citation Analysis]
28 Han IW, Jang JY, Lee KB, Kang MJ, Kwon W, Park JW, Chang YR, Kim SW. Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin. HPB (Oxford) 2014;16:575-81. [PMID: 24308425 DOI: 10.1111/hpb.12193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
29 Kimura N, Young AL, Toyoki Y, Wyatt JI, Toogood GJ, Hidalgo E, Prasad KR, Kudo D, Ishido K, Hakamada K, Lodge JPA. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors. Surgery. 2017;162:500-514. [PMID: 28551378 DOI: 10.1016/j.surg.2017.03.017] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
30 Tang W, Qiu JG, Deng X, Liu SS, Cheng L, Liu JR, Du CY. Minimally invasive versus open radical resection surgery for hilar cholangiocarcinoma: Comparable outcomes associated with advantages of minimal invasiveness. PLoS One 2021;16:e0248534. [PMID: 33705481 DOI: 10.1371/journal.pone.0248534] [Reference Citation Analysis]
31 Ratti F, Cipriani F, Piozzi G, Catena M, Paganelli M, Aldrighetti L. Comparative Analysis of Left- Versus Right-sided Resection in Klatskin Tumor Surgery: can Lesion Side be Considered a Prognostic Factor? J Gastrointest Surg 2015;19:1324-33. [DOI: 10.1007/s11605-015-2840-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
32 Coelen RJS, Vogel JA, Vroomen LGPH, Roos E, Busch ORC, van Delden OM, Delft FV, Heger M, van Hooft JE, Kazemier G, Klümpen HJ, van Lienden KP, Rauws EAJ, Scheffer HJ, Verheul HM, Vries J, Wilmink JW, Zonderhuis BM, Besselink MG, van Gulik TM, Meijerink MR. Ablation with irreversible electroporation in patients with advanced perihilar cholangiocarcinoma (ALPACA): a multicentre phase I/II feasibility study protocol. BMJ Open 2017;7:e015810. [PMID: 28864693 DOI: 10.1136/bmjopen-2016-015810] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
33 Deoliveira ML, Schulick RD, Nimura Y, Rosen C, Gores G, Neuhaus P, Clavien PA. New staging system and a registry for perihilar cholangiocarcinoma. Hepatology. 2011;53:1363-1371. [PMID: 21480336 DOI: 10.1002/hep.24227] [Cited by in Crossref: 187] [Cited by in F6Publishing: 209] [Article Influence: 18.7] [Reference Citation Analysis]
34 Bhardwaj N, Garcea G, Dennison AR, Maddern GJ. The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade? World J Surg 2015;39:2748-56. [PMID: 26133907 DOI: 10.1007/s00268-015-3125-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
35 Ruys AT, Busch OR, Rauws EA, Gouma DJ, van Gulik TM. Prognostic impact of preoperative imaging parameters on resectability of hilar cholangiocarcinoma. HPB Surg 2013;2013:657309. [PMID: 23861556 DOI: 10.1155/2013/657309] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
36 Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258:129-140. [PMID: 23059502 DOI: 10.1097/sla.0b013e3182708b57] [Cited by in Crossref: 321] [Cited by in F6Publishing: 147] [Article Influence: 40.1] [Reference Citation Analysis]
37 Ribero D, Zimmitti G, Aloia TA, Shindoh J, Fabio F, Amisano M, Passot G, Ferrero A, Vauthey JN. Preoperative Cholangitis and Future Liver Remnant Volume Determine the Risk of Liver Failure in Patients Undergoing Resection for Hilar Cholangiocarcinoma. J Am Coll Surg. 2016;223:87-97. [PMID: 27049784 DOI: 10.1016/j.jamcollsurg.2016.01.060] [Cited by in Crossref: 65] [Cited by in F6Publishing: 50] [Article Influence: 13.0] [Reference Citation Analysis]
38 van der Gaag N, Kloek J, de Bakker J, Musters B, Geskus R, Busch O, Bosma A, Gouma D, van Gulik T. Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma. Annals of Oncology 2012;23:2642-9. [DOI: 10.1093/annonc/mds077] [Reference Citation Analysis]
39 Stremitzer S, Jones RP, Quinn LM, Fenwick SW, Diaz-Nieto R, Poston GJ, Malik HZ. Clinical outcome after resection of early-stage hilar cholangiocarcinoma. Eur J Surg Oncol. 2019;45:213-217. [PMID: 30360988 DOI: 10.1016/j.ejso.2018.09.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
40 Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg 2014;399:693-705. [PMID: 24841192 DOI: 10.1007/s00423-014-1210-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
41 Rassam F, Roos E, van Lienden KP, van Hooft JE, Klümpen HJ, van Tienhoven G, Bennink RJ, Engelbrecht MR, Schoorlemmer A, Beuers UHW, Verheij J, Besselink MG, Busch OR, van Gulik TM. Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience. Langenbecks Arch Surg 2018;403:289-307. [PMID: 29350267 DOI: 10.1007/s00423-018-1649-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
42 Dumitrascu T, Chirita D, Ionescu M, Popescu I. Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome. J Gastrointest Surg. 2013;17:913-924. [PMID: 23319395 DOI: 10.1007/s11605-013-2144-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 6.5] [Reference Citation Analysis]
43 Komaya K, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M. Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: A propensity score matching analysis of resectable perihilar cholangiocarcinoma. Surgery. 2017;161:394-404. [PMID: 27712872 DOI: 10.1016/j.surg.2016.08.008] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 10.4] [Reference Citation Analysis]
44 Gomez D, Patel P, Lacasia-purroy C, Byrne C, Sturgess R, Palmer D, Fenwick S, Poston G, Malik H. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma. European Journal of Surgical Oncology (EJSO) 2014;40:77-84. [DOI: 10.1016/j.ejso.2013.10.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
45 Chang YR, Lee KB, Jang J, Lim C, Kang MJ, Kwon W, Jung WH, Kim S. Analysis of Microscopic Tumor Spread Patterns According to Gross Morphologies and Suggestions for Optimal Resection Margins in Bile Duct Cancer. J Gastrointest Surg 2014;18:1146-54. [DOI: 10.1007/s11605-014-2518-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
46 Dekker AM, Wiggers JK, Coelen RJ, van Golen RF, Besselink MG, Busch OR, Verheij J, Hollmann MW, van Gulik TM. Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma. HPB (Oxford) 2016;18:262-70. [PMID: 27017166 DOI: 10.1016/j.hpb.2015.08.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
47 Riechelmann R, Coutinho AK, Weschenfelder RF, Andrade DE Paulo G, Fernandes Gdos S, Gifoni M, Oliveira Mde L, Gansl R, Gil R, Luersen G, Lucas L, Reisner M, Vieira FM, Machado MA, Murad A, Osvaldt A, Brandão M, Carvalho E, Souza T, Pfiffer T, Prolla G. GUIDELINE FOR THE MANAGEMENT OF BILE DUCT CANCERS BY THE BRAZILIAN GASTROINTESTINAL TUMOR GROUP. Arq Gastroenterol 2016;53:5-9. [PMID: 27276097 DOI: 10.1590/S0004-28032016000100003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
48 Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014;3:18-34. [PMID: 24696835 DOI: 10.3978/j.issn.2304-3881.2014.02.05] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
49 Saito H, Noji T, Okamura K, Tsuchikawa T, Shichinohe T, Hirano S. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma. Surgery 2016;159:842-51. [DOI: 10.1016/j.surg.2015.10.027] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
50 Mehrabi A, Khajeh E, Ghamarnejad O, Nikdad M, Chang D, Büchler MW, Hoffmann K. Meta-analysis of the efficacy of preoperative biliary drainage in patients undergoing liver resection for perihilar cholangiocarcinoma. European Journal of Radiology 2020;125:108897. [DOI: 10.1016/j.ejrad.2020.108897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
51 DeOliveira ML, Kambakamba P, Clavien PA. Advances in liver surgery for cholangiocarcinoma. Curr Opin Gastroenterol. 2013;29:293-298. [PMID: 23563982 DOI: 10.1097/mog.0b013e3283600a92] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
52 Franken LC, van der Poel MJ, Latenstein AEJ, Zwart MJ, Roos E, Busch OR, Besselink MG, van Gulik TM. Minimally invasive surgery for perihilar cholangiocarcinoma: a systematic review. J Robot Surg 2019;13:717-27. [PMID: 31049774 DOI: 10.1007/s11701-019-00964-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
53 Cheng QB, Yi B, Wang JH, Jiang XQ, Luo XJ, Liu C, Ran RZ, Yan PN, Zhang BH. Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV. Eur J Surg Oncol. 2012;38:1197-1203. [PMID: 22992326 DOI: 10.1016/j.ejso.2012.08.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
54 Coelen RJ, Wiggers JK, Nio CY, Besselink MG, Busch OR, Gouma DJ, van Gulik TM. Preoperative computed tomography assessment of skeletal muscle mass is valuable in predicting outcomes following hepatectomy for perihilar cholangiocarcinoma. HPB (Oxford) 2015;17:520-8. [PMID: 25726722 DOI: 10.1111/hpb.12394] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
55 Lee J, Kang SH, Noh OK, Chun M, Oh YT, Kim BW, Kim SW. Adjuvant concurrent chemoradiation therapy in patients with microscopic residual tumor after curative resection for extrahepatic cholangiocarcinoma. Clin Transl Oncol. 2018;20:1011-1017. [PMID: 29256155 DOI: 10.1007/s12094-017-1815-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
56 Higuchi R, Ota T, Yazawa T, Kajiyama H, Araida T, Furukawa T, Yoshikawa T, Takasaki K, Yamamoto M. Improved surgical outcomes for hilar cholangiocarcinoma: changes in surgical procedures and related outcomes based on 40 years of experience at a single institution. Surg Today 2016;46:74-83. [DOI: 10.1007/s00595-015-1119-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
57 Nakahashi K, Ebata T, Yokoyama Y, Igami T, Mizuno T, Yamaguchi J, Onoe S, Watanabe N, Nagino M. How long should follow-up be continued after R0 resection of perihilar cholangiocarcinoma? Surgery 2020;168:617-24. [PMID: 32665142 DOI: 10.1016/j.surg.2020.04.068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
58 Ratti F, Cipriani F, Ferla F, Catena M, Paganelli M, Aldrighetti LAM. Hilar Cholangiocarcinoma: Preoperative Liver Optimization with Multidisciplinary Approach. Toward a Better Outcome. World J Surg 2013;37:1388-96. [DOI: 10.1007/s00268-013-1980-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
59 Al Mahjoub A, Menahem B, Fohlen A, Dupont B, Alves A, Launoy G, Lubrano J. Preoperative Biliary Drainage in Patients with Resectable Perihilar Cholangiocarcinoma: Is Percutaneous Transhepatic Biliary Drainage Safer and More Effective than Endoscopic Biliary Drainage? A Meta-Analysis. Journal of Vascular and Interventional Radiology 2017;28:576-82. [DOI: 10.1016/j.jvir.2016.12.1218] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 11.5] [Reference Citation Analysis]
60 Jayant K, Sodergren MH, Reccia I, Kusano T, Zacharoulis D, Spalding D, Pai M, Jiao LR, Huang KW. A Systematic Review and Meta-Analysis Comparing Liver Resection with the Rf-Based Device Habib™-4X with the Clamp-Crush Technique. Cancers (Basel) 2018;10:E428. [PMID: 30413094 DOI: 10.3390/cancers10110428] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
61 Ohiwa T, Ebata T, Mizuno T, Yokoyama Y, Yamaguchi J, Onoe S, Watanabe N, Nagino M. Occult synchronous liver metastasis from perihilar cholangiocarcinoma. Surgery 2019;166:290-6. [PMID: 31235246 DOI: 10.1016/j.surg.2019.04.029] [Reference Citation Analysis]
62 Nagino M. Perihilar cholangiocarcinoma: a surgeon’s viewpoint on current topics. J Gastroenterol. 2012;47:1165-1176. [PMID: 22847554 DOI: 10.1007/s00535-012-0628-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
63 Okuno M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M. Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma. J Gastroenterol 2016;51:153-61. [PMID: 26187429 DOI: 10.1007/s00535-015-1103-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]